Skip Navigation

Holcombe E. Grier, MD

Pediatric Hematology/Oncology

Make an Appointment


  • Distinguished Staff
  • Professor of Pediatrics, Emeritus, Harvard Medical School


Clinical Interests

  • Ewing sarcoma
  • Non-rhabdomyosarcoma soft tissue sarcoma (NRSTS)
  • Osteosarcoma
  • Rhabdomyosarcoma

Contact Information


Dr. Grier received his MD from the University of Pennsylvania in 1976, and then trained in pediatrics, internal medicine, and infectious disease at the University of North Carolina. He joined Dana-Farber Cancer Institute in 1984. He is a past president of the American Society of Pediatric Hematology/Oncology and is a member of the steering committee for Bone Tumors in the Children's Oncology Group.

Board Certification:

  • Internal Medicine, 1980
  • Pediatric Hematology/Oncology, 1990
  • Pediatrics, 1983


  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology


  • North Carolina Memorial Hospital

Medical School:

  • University of Pennsylvania School of Medicine

Recent Awards:

  • Harvard Medical School Faculty Prize for Excellence in Teaching [Years III and IV] 2008
  • Stephen Sallan Leadership Award, Dana Farber Cancer Institute, Boston, MA 2007
  • Ronald L Chard, Jr. Memorial Lecture, Childrens Hospital and Memorial Medical Center, Seattle, WA. 2008
  • Harvard Medical School Community Service Award 2009
  • Charles A. Janeway Award for Excellence in Clinical Teaching, Children's Hospital House Staff, Boston 1992


Pediatric Sarcomas

At the Children's Oncology Group, we work on the design and implementation of studies regarding Ewing sarcoma, osteosarcoma, rhabdomyosarcoma, and other soft tissue sarcomas. The Children's Oncology Group is a consortium of cancer treatment centers across the United States, Canada, and other countries. Dr. Grier is an active member of the Bone Tumor Disease Committee and the Soft Tissue Sarcoma Committee of this group. As part of the Pediatric Solid Tumor Center at Dana-Farber/Boston Children's, we help organize laboratory and clinical cross talk. We are also involved in cancer survivor studies that focus on the late effects of chemotherapy. These studies are led by Dr. Lisa Diller at the David B. Perini Jr. Quality of Life Clinic at Dana-Farber Cancer Institute. In addition, we participate in a study of the best application of palliative care through our work with the Pediatric Advanced Care Team, led by Dr. Joanne Wolfe.

Research Departments:


Dana-Farber Cancer Institute
450 Brookline Avenue
Dana G350
Boston, MA 02215
Get Directions